Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jatinder K Lamba

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Pharmacogenomics|October 22, 2009
Genetic factors influencing cytarabine therapyJatinder K Lamba
Pharmacogenomics|December 25, 2007
Pharmacogenetics of the constitutive androstane receptorJatinder K Lamba
Cancers|July 29, 2023
Current Landscape of Genome-Wide Association Studies in Acute Myeloid Leukemia: A ReviewRichard J Marrero, Jatinder K Lamba
Future Oncology (London, England)|July 25, 2018
Gemtuzumab ozogamicin for treatment of newly diagnosed CD33-positive acute myeloid leukemiaMohammed Gbadamosi, Soheil Meshinchi, Jatinder K Lamba
BMC Research Notes|March 11, 2014
Identification of suitable reference genes for hepatic microRNA quantitationVishal Lamba, Yogita Ghodke-Puranik, Weihua Guan, et al.
Advanced Drug Delivery Reviews|October 31, 2002
Genetic contribution to variable human CYP3A-mediated metabolismJatinder K Lamba, Yvonne S Lin, Erin G Schuetz, et al.
Immunotherapy|April 24, 2025
CD33-D2 isoform characterization for advancement of its therapeutic potentialVivek M Shastri, Srideshikan Sargur Madabushi, Susanta K Hui, et al.
Genes|April 27, 2019
MicroRNAs Mediated Regulation of Expression of Nucleoside Analog Pathway Genes in Acute Myeloid LeukemiaNeha S Bhise, Abdelrahman H Elsayed, Xueyuan Cao, et al.
Cancers|December 16, 2020
Functional Dependency Analysis Identifies Potential Druggable Targets in Acute Myeloid LeukemiaYujia Zhou, Gregory P Takacs, Jatinder K Lamba, et al.
Toxicology and Applied Pharmacology|September 15, 2004
PXR (NR1I2): splice variants in human tissues, including brain, and identification of neurosteroids and nicotine as PXR activatorsVishal Lamba, Kazuto Yasuda, Jatinder K Lamba, et al.
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Pharmacogenomics|October 22, 2009
Genetic factors influencing cytarabine therapyJatinder K Lamba
Pharmacogenomics|December 25, 2007
Pharmacogenetics of the constitutive androstane receptorJatinder K Lamba
Cancers|July 29, 2023
Current Landscape of Genome-Wide Association Studies in Acute Myeloid Leukemia: A ReviewRichard J Marrero, Jatinder K Lamba
Future Oncology (London, England)|July 25, 2018
Gemtuzumab ozogamicin for treatment of newly diagnosed CD33-positive acute myeloid leukemiaMohammed Gbadamosi, Soheil Meshinchi, Jatinder K Lamba
BMC Research Notes|March 11, 2014
Identification of suitable reference genes for hepatic microRNA quantitationVishal Lamba, Yogita Ghodke-Puranik, Weihua Guan, et al.
Advanced Drug Delivery Reviews|October 31, 2002
Genetic contribution to variable human CYP3A-mediated metabolismJatinder K Lamba, Yvonne S Lin, Erin G Schuetz, et al.
Immunotherapy|April 24, 2025
CD33-D2 isoform characterization for advancement of its therapeutic potentialVivek M Shastri, Srideshikan Sargur Madabushi, Susanta K Hui, et al.
Genes|April 27, 2019
MicroRNAs Mediated Regulation of Expression of Nucleoside Analog Pathway Genes in Acute Myeloid LeukemiaNeha S Bhise, Abdelrahman H Elsayed, Xueyuan Cao, et al.
Cancers|December 16, 2020
Functional Dependency Analysis Identifies Potential Druggable Targets in Acute Myeloid LeukemiaYujia Zhou, Gregory P Takacs, Jatinder K Lamba, et al.
Toxicology and Applied Pharmacology|September 15, 2004
PXR (NR1I2): splice variants in human tissues, including brain, and identification of neurosteroids and nicotine as PXR activatorsVishal Lamba, Kazuto Yasuda, Jatinder K Lamba, et al.
Pageof 8